[{"AccountsPayableCurrent_0_Q1_USD":3176000.0,"LongTermDebtCurrent_0_Q1_USD":16969000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":296000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":958000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":108871000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":5.57,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":33.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1148000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":131000.0,"NonoperatingIncomeExpense_1_Q1_USD":-743000.0,"LongTermDebt_0_Q1_USD":16969000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":856000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":1.04,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":3.78,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":2760000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":18000.0,"DebtInstrumentUnamortizedDiscount_0_Q1_USD":1656000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q1_USD":0.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2360000.0,"IncreaseDecreaseInInventories_1_Q1_USD":635000.0,"RepaymentsOfNotesPayable_1_Q1_USD":2100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q1_shares":883000.0,"PaidInKindInterest_1_Q1_USD":379000.0,"InventoryRawMaterialsAndSuppliesNetOfReserves_0_Q1_USD":2138000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-639000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":127000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":127000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":318000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-9167000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":328000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":445000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q1_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":0.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":328000.0,"AccountsReceivableGrossCurrent_0_Q1_USD":5628000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":2156000.0,"ProceedsFromLinesOfCredit_1_Q1_USD":761000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":8144000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":1.04,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":1473000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q1_USD":6.03,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":0.0,"ProceedsFromIssuanceOfSecuredDebt_1_Q1_USD":0.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":1513000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.014,"LiabilitiesCurrent_0_Q1_USD":23188000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":19102000.0,"Liabilities_0_Q1_USD":23315000.0,"InventoryNet_0_Q1_USD":3611000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-53000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-1261000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":477000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":5000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-10505000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.3,"CostsAndExpenses_1_Q1_USD":10042000.0,"CommonStockValue_0_Q1_USD":3000.0,"CommonStockSharesOutstanding_0_Q1_shares":37752000.0,"CommonStockSharesIssued_0_Q1_shares":37752000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":8144000.0,"AssetsCurrent_0_Q1_USD":16982000.0,"Assets_0_Q1_USD":19102000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":26888000.0,"AccountsReceivableNetCurrent_0_Q1_USD":4115000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-1135000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":0.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-8032000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":1112000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.7,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":328000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":7368000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":2674000.0,"OperatingIncomeLoss_1_Q1_USD":-9762000.0,"InterestPaidNet_1_Q1_USD":382000.0,"InterestExpense_1_Q1_USD":761000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":18625000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":2725000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":35569000.0,"StockholdersEquity_0_Q1_USD":-4213000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-113087000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2120000.0,"ProfitLoss_1_Q1_USD":-10510000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":0.0,"NetIncomeLoss_1_Q1_USD":-10510000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1136000.0,"Ticker":"BNGO","CIK":"1411690","name":"BIONANO GENOMICS, INC","OfficialName":"Bionano Genomics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"573433639.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NASDAQ","SP500":"nan","filed":"20200618"}]